VRDN Viridian Therapeutics, Inc.

NASDAQ
$31.44

Viridian Therapeutics, Inc. (VRDN) SEC Filings

Everything VRDN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

48 filings
Date Form Filing
SCHEDULE 13G
8-K Investor Presentation · Other · Other Event · Other Reg Fd · Reg Fd
10-Q
8-K Earnings Release · Guidance Update
4
SCHEDULE 13G
144
4
10-Q
4
4
4
4
4
4
4
10-Q
4/A
4/A
4/A
4/A
4
4
4/A
4/A
4
4
4
10-K
4
10-Q
4
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.